| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $344.6M | $327.5M | $297.6M |
| YoY Revenue Growth % | +5.2% | +10.0% | — |
| Gross Profit | $178.1M | $170.9M | — |
| Gross Margin % | 51.7% | 52.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$34.0M | -$47.9M | -$76.8M |
| Operating Margin % | -9.9% | -14.6% | -25.8% |
| Net Income (GAAP) | -$27.6M | -$34.9M | -$59.0M |
| EBITDA (Normalized) | -$33.4M | -$47.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $33.9M | $39.7M | $7.3M |
| Capital Expenditures (CapEx) | $810.0K | $637.0K | — |
| Free Cash Flow (FCF) | $33.1M | $39.1M | $7.3M |
| FCF Margin % | 9.6% | 11.9% | 2.4% |
| Return on Invested Capital (ROIC %) | -20.3% | -45.0% | — |
| Cash & Short-Term Equivalents | $162.2M | $371.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $294.8M | $382.3M | — |